NO20011670L - Preparat for parenteral administrering av aktive forbindelser - Google Patents

Preparat for parenteral administrering av aktive forbindelser

Info

Publication number
NO20011670L
NO20011670L NO20011670A NO20011670A NO20011670L NO 20011670 L NO20011670 L NO 20011670L NO 20011670 A NO20011670 A NO 20011670A NO 20011670 A NO20011670 A NO 20011670A NO 20011670 L NO20011670 L NO 20011670L
Authority
NO
Norway
Prior art keywords
preparation
parenteral administration
active compounds
carrier material
linear
Prior art date
Application number
NO20011670A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011670D0 (no
Inventor
Juergen Grande
Silke Schuth
Gitte Boehm
Holger Bengs
Original Assignee
Celanese Ventures Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celanese Ventures Gmbh filed Critical Celanese Ventures Gmbh
Publication of NO20011670D0 publication Critical patent/NO20011670D0/no
Publication of NO20011670L publication Critical patent/NO20011670L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20011670A 1998-10-15 2001-04-03 Preparat for parenteral administrering av aktive forbindelser NO20011670L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998147593 DE19847593A1 (de) 1998-10-15 1998-10-15 Zusammensetzung für die parenterale Applikation von Wirkstoffen
PCT/EP1999/007300 WO2000021505A2 (fr) 1998-10-15 1999-10-02 Composition pour administration parenterale de principes actifs

Publications (2)

Publication Number Publication Date
NO20011670D0 NO20011670D0 (no) 2001-04-03
NO20011670L true NO20011670L (no) 2001-06-12

Family

ID=7884587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011670A NO20011670L (no) 1998-10-15 2001-04-03 Preparat for parenteral administrering av aktive forbindelser

Country Status (8)

Country Link
EP (1) EP1124538A2 (fr)
JP (1) JP2002527376A (fr)
AU (1) AU6198999A (fr)
CA (1) CA2346670A1 (fr)
DE (1) DE19847593A1 (fr)
NO (1) NO20011670L (fr)
PL (1) PL347770A1 (fr)
WO (1) WO2000021505A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022095B4 (de) * 2000-05-08 2005-07-14 Südzucker AG Mannheim/Ochsenfurt Gel aus einem Poly-α-1,4-Glucan und Stärke
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
WO2005070213A2 (fr) 2004-01-23 2005-08-04 Eden Research Plc Compositions nematicides et leur mode d'emploi
MXPA06013420A (es) 2004-05-20 2007-03-01 Eden Research Plc Composiciones que contienen una particula hueca de glucano o una particula de pared celular que encapsula un componente de terpeno, metodos para elaborar y usar las mismas.
US20080227805A1 (en) 2007-02-28 2008-09-18 Abbott Laboratories Sustained release parenteral formulations of buprenorphine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2646879A1 (de) * 1975-10-21 1977-05-05 Takeda Chemical Industries Ltd Matrix aus einem in wasser unloeslichen beta-1,3-glucangel und verfahren zu ihrer herstellung
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
IL113776A (en) * 1994-05-18 2008-12-29 Bayer Bioscience Gmbh Dna sequences coding for enzymes which catalyze the synthesis of linear alpha 1,4 - glucans in plants, fungi and microorganisms
DE19737481A1 (de) * 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
DE59909854D1 (de) * 1998-04-09 2004-08-05 Celanese Ventures Gmbh Partikulärer wirkstoffträger für die pulmonale applikation
DE19839216C1 (de) * 1998-08-28 2000-01-20 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von sphärischen Mikropartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen Verzweigungen enthaltenden Polyglucan bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und die Verwendung

Also Published As

Publication number Publication date
DE19847593A1 (de) 2000-04-20
WO2000021505A3 (fr) 2000-09-21
PL347770A1 (en) 2002-04-22
NO20011670D0 (no) 2001-04-03
AU6198999A (en) 2000-05-01
CA2346670A1 (fr) 2000-04-20
JP2002527376A (ja) 2002-08-27
WO2000021505A2 (fr) 2000-04-20
EP1124538A2 (fr) 2001-08-22

Similar Documents

Publication Publication Date Title
EA199900467A2 (ru) Составы на основе зипразидона
TR200100708T2 (tr) İlaç maddelerine mahsus çabuk salımlı farmasötik bileşimler.
DE59811487D1 (de) Mehrphasige wirkstoffhaltige Zubereitungsformen
AU2003304237A1 (en) Gel-stabilized nanoparticulate active agent compositions
FR2831820B1 (fr) Comprime orodispersible presentant une grande homogeneite et son procede de preparation
CA2029524A1 (fr) Administration transdermique de la 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
CA2282513A1 (fr) Stabilisation de benzimidazoles sensibles aux acides avec des combinaisons amino-cyclodextrine
WO2005009144A8 (fr) Formulations pulverulentes a base de phytosterols
CA2345121A1 (fr) Composition pharmaceutique pour le traitement des maladies aigues
LU91613I2 (fr) Paclitaxel albumin (Abraxane - paclitaxel)
DE60121857D1 (de) Arzneimittelzusammensetzung mit verzögerter Wirkstoffabgabe
IT1309592B1 (it) Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
CA2339991A1 (fr) Microemulsions comme formes pharmaceutiques solides destinees a une administration orale
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
PL340266A1 (en) Pharmacologically active composition containing artemisinin and/or its derivative
NO20011670L (no) Preparat for parenteral administrering av aktive forbindelser
DE69622739D1 (de) Pharmazeutische zubereitung mit schneller freisetzung
HUP0100303A2 (hu) Porózus hidroxiapatit részecskék mint gyógyszerhatóanyag hordozók
AU5673399A (en) Compositions and methods for treating intracellular infections
AU648890B2 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist
NO20004816L (no) Ny farmasøytisk formulering
NO944956D0 (no) Preparat for lokal anvendelse, fremgangsmåte for fremstilling av slike, samt anvendelse av disse
EP1086933A3 (fr) Composition de ciment
BR9711884A (pt) Produto perfumado e uso de pelo menos um de amberlyn super pm 577, folha de cravo, di-hidro-mircenol, fenil-propil-álcool e alfa-terpineol.
YU70493A (sh) Stabilan vodeno rastvoran veterinarski preparat i postupak za njegovo dobijanje

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application